ESC 2023: IV Ferric Carboxymaltose Safe, Modestly Effective in HFrEF With Iron Deficiency
Modest improvement seen in death rate, hospitalization, and six-minute walk distance compared with placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.